Glycemia at admission: The metabolic echocardiography in acute coronary syndrome patients

European Journal of Preventive Cardiology

Volumn 16, Issue 2, 2009, Pages 164-168

  Monteiro, Silvia ^a   António, Natália ^a   Gonçalves, Francisco ^a   Monteiro, Pedro ^a,b   Freitas, Mário ^a,b   Providência, Luis A ^a,b  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

acute coronary syndrome; admission glycemia; metabolic control; prognosis; stress hyperglycemia; ventricular dysfunction

Indexed keywords

ACUTE CORONARY SYNDROME; AGE; AGED; ARTICLE; ECHOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MALE; MIDDLE AGED; MORTALITY; PREDICTION AND FORECASTING; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; ARTERY DISEASE; CARDIAC PATIENT; CARDIOGENIC SHOCK; CARDIOVASCULAR RISK; COMORBIDITY; CREATININE CLEARANCE; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART ARREST; HEART FAILURE; HEART INFARCTION; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE NECROSIS; HEART RATE; HEART VENTRICLE FIBRILLATION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HOSPITALIZATION; HYPERTENSION; LUNG EDEMA; MAJOR CLINICAL STUDY; PREDICTION; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION; STROKE; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; AGE FACTORS; AGED; FEMALE; FOLLOW-UP STUDIES; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; TRIACYLGLYCEROL; TROPONIN I;

EID: 67449105706     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/HJR.0b013e328323ad75     Document Type: Article

References (30)

1. Steg PG, Dabbous OH, Feldman LJ, Cohen-Solal A, Aumont MC, López-Sendón J, et al. Global registry of acute coronary events investigators. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events. Circulation 2004; 109: 494–499.
2. Hasdai D, Topol EJ, Kilaru R, Battler A, Harrington RA, Vahanian A, et al. Frequency, patient characteristics and outcome of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials. Am Heart J 2003; 145: 73–79.
3. Wu AH, Parsons L, Every NR, Bates ER, Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction (NRMI-2) J Am Coll Cardiol 2002; 105: 2605–2610.
4. Nieminen M, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, on behalf of the EuroHeart Survey Investigators. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur Heart J 2006; 27: 2725–2736.
5. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000; 355: 773–778.
6. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes. Circulation 2005; 111: 3078–3086.
7. Ishihara M, Kojima S, Sakamato T, Asada Y, Tei C, Kimura K, et al. Japanese Acute Coronary Syndrome Study Investigators. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 2005; 150: 814–820.
8. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 2003; 41: 1–7.
9. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol 2002; 40: 1748–1754.
10. Meier JJ, Deifuss S, Klamann A, Launhardt V, Schmiegel WH, Nauck MA. Plasma glucose at hospital admission and previous metabolic control determine myocardial infarct size and survival in patients with and without type 2 diabetes: the Langendreer myocardial infarction and blood glucose in diabetic patients assessment (LAMBDA). Diabetes Care 2005; 28: 2551–2553.
11. Straumann E, Kurz DJ, Muntwyler J, Stettler I, Furrer M, Naegeli B, et al. Admission glucose concentrations independently predict early and late mortality in patients with acute myocardial infarction treated by primary or rescue percutaneous coronary intervention. Am Heart J 2005; 150: 1000–1006.
12. Petursson P, Herlitz J, Caidahl K, Gudbjörnsdottir S, Karlsson T, Perers E, et al. Admission glycaemia and outcome after acute coronary syndrome. Int J Cardiol 2007; 116: 315–320.
13. Dirkali A, van der Ploeg TJ, Nangrahary M, Cornel JH, Umans V. The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction. Int J Cardiol 2007; 121: 215–217.
14. Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Non-ST-segment elevation acute coronary syndromes (Guidelines for the diagnosis and treatment of). Eur Heart J 2007; 28: 1598–1660.
15. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KAA, et al. Acute myocardial infarction in patients presenting with ST-segment elevation (Management of). Eur Heart J 2003; 24: 28–66.
16. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro heart survey on diabetes and the heart. Eur Heart J 2004; 25: 1880–1890.
17. Norhammar A, Lindbäck J, Ryden L, Wallentin L, Stenestrand U, for the Register of Information Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Improved but still high short and long-term mortality after myocardial infarction in patients with diabetes mellitus. A time trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission Heart 2007; 93: 1577–1583.
18. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E, et al. A prospective survey of the characteristics, treatments and outcome of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro heart survey of acute coronary syndromes. Eur Heart J 2002; 23: 1190–1201.
19. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, et al. GRACE Investigators. Decline in rates of death and heart failure in acute coronary syndromes, 1999–2006. JAMA 2007; 297: 1892–1900.
20. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, et al. Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 2005; 111: 754–760.
21. Goyal A, Mahaffey K, Garg J, Nicolau JC, Hochman JS, Weaver WD, et al. Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 2006; 27: 1289–1297.
22. Kosiborod M, Inzucchi S, Krumholz H, Xiao L, Jones P, Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction. Defining the optimal outcomes-based measure of risk Circulation 2008; 117: 1018–1027.
23. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendíc S, Rydén L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140–2144.
24. Bartnik M, Malmberg K, Norhammar A, Tenerz A, Ohrvik J, Ryden L. Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J 2005; 25: 1990–1997.
25. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, et al. Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J 2006; 27: 2413–2419.
26. Ceriello A. Acute hyperglycaemia: a ‘new’ risk factor during myocardial infarction. Eur Heart J 2005; 26: 328–331.
27. Nesto R. Diabetes, hyperglycemia, and the cardiologist: a call to action for optimizing care Rev Cardiovasc Med 2006; 7 (Suppl 2):S1–S2.
28. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, et al. Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diab Care 2003; 26: 3129–3135.
29. Zarich S, Nesto R. Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction. Circulation 2007; 115: e436–e439.
30. Timmer J, Ottervanger J, de Boer M, Dambrink JE, Hoorntje JCA, Gosselink ATM, et al. for the Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 2005; 45: 999–1002.